Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-23-000008

Chief Medical Officer returned 3,708 shares (to the company)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Nuyten Dimitry SA · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-18 Returned to the company : show line 1 in the form 10b5-1 −3,708 $20.40 $75,643 73,591 D
Loading xslF345X05/wk-form4_1695242857.xml…